Our Customers

Pediatric Probiotics: Meeting the Needs of Early-Life Microbiome Development

06 - May - 2026

The infant and kids’ probiotics market continues to expand with new formulations designed for immunity, digestive balance, and early-life microbiome development. Valued at approximately $5.1 billion in 2025, this segment is experiencing strong double-digit growth as parents increasingly prioritize preventive solutions backed by clinical research.

 

Pediatric Probiotics: Meeting the Needs of Early-Life Microbiome Development

 

Emerging research demonstrates that targeted probiotic strains can reduce infection duration and support healthy immune responses in children, a trend reinforced by consumer demand for safe, strain-specific products. Innovation in this space is focusing on delivery systems, including chewables, drops, and functional foods, as well as dual maternal-child health formulations that link prenatal and pediatric wellness through the microbiome.

According to MarketsandMarkets, dietary supplements are projected to be the fastest-growing product segment in the probiotics market. The online channel for gut health probiotics reached 2.89 billion RMB in sales, reflecting strong digital engagement. With the popularization of the “prevent disease before it occurs” health concept, especially among younger generations, probiotics have become a new norm for family health care.